(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LGALS3 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO Lgals3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LGALS3 mRNA CTD PMID:36331819 1,1-dichloroethene increases expression ISO Lgals3 (Mus musculus) 6480464 vinylidene chloride results in increased expression of LGALS3 mRNA CTD PMID:26682919 1,4-dichlorobenzene increases expression ISO Lgals3 (Mus musculus) 6480464 4-dichlorobenzene results in increased expression of LGALS3 mRNA CTD PMID:26975756 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of LGALS3 mRNA CTD PMID:17522070 more ... 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of LGALS3 mRNA CTD PMID:17557909 17beta-estradiol affects expression ISO Lgals3 (Mus musculus) 6480464 Estradiol affects the expression of LGALS3 mRNA CTD PMID:15598610 17beta-estradiol multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA and [Estradiol co-treated with Progesterone] results in decreased expression of LGALS3 mRNA CTD PMID:20660070 and PMID:20823114 17beta-estradiol increases expression ISO Lgals3 (Mus musculus) 6480464 Estradiol results in increased expression of LGALS3 mRNA CTD PMID:15289156 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Lgals3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of LGALS3 mRNA CTD PMID:20159946 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Lgals3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA CTD PMID:17035482 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO LGALS3 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA CTD PMID:11489354 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Lgals3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of LGALS3 mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA CTD PMID:20959002 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LGALS3 mRNA CTD PMID:22298810 and PMID:34747641 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO LGALS3 (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 2-hydroxypropanoic acid increases expression ISO LGALS3 (Homo sapiens) 6480464 Lactic Acid results in increased expression of LGALS3 mRNA CTD PMID:30851411 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of LGALS3 mRNA CTD PMID:15890375 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO LGALS3 (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of LGALS3 protein CTD PMID:31675489 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of LGALS3 mRNA CTD PMID:28522335 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of LGALS3 protein CTD PMID:34915118 3-methylcholanthrene increases expression ISO Lgals3 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of LGALS3 mRNA CTD PMID:20713471 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of LGALS3 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of LGALS3 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol decreases expression ISO LGALS3 (Homo sapiens) 6480464 bisphenol S results in decreased expression of LGALS3 mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol increases expression ISO LGALS3 (Homo sapiens) 6480464 bisphenol S results in increased expression of LGALS3 protein CTD PMID:34186270 4,4'-sulfonyldiphenol decreases methylation ISO Lgals3 (Mus musculus) 6480464 bisphenol S results in decreased methylation of LGALS3 exon CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO Lgals3 (Mus musculus) 6480464 bisphenol S results in increased expression of LGALS3 mRNA CTD PMID:30951980 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of LGALS3 mRNA CTD PMID:15890375 4-hydroxyphenyl retinamide decreases expression ISO Lgals3 (Mus musculus) 6480464 Fenretinide results in decreased expression of LGALS3 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO LGALS3 (Homo sapiens) 6480464 Decitabine results in increased expression of LGALS3 mRNA CTD PMID:19194470 5-fluorouracil affects response to substance ISO LGALS3 (Homo sapiens) 6480464 LGALS3 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 5-fluorouracil multiple interactions EXP 150530464 5-fluorouracil inhibits the reaction [N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum] RGD 5-fluorouracil decreases response to substance ISO LGALS3 (Homo sapiens) 6480464 LGALS3 protein mutant form results in decreased susceptibility to Fluorouracil CTD PMID:21750908 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of LGALS3 mRNA CTD PMID:24780913 7,12-dimethyltetraphene affects expression ISO Lgals3 (Mus musculus) 6480464 9 more ... CTD PMID:21785161 acetamide increases expression EXP 6480464 acetamide results in increased expression of LGALS3 mRNA CTD PMID:31881176 actinomycin D multiple interactions ISO LGALS3 (Homo sapiens) 6480464 Dactinomycin inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] CTD PMID:21821001 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of LGALS3 mRNA CTD PMID:15890375 aflatoxin B1 increases expression ISO LGALS3 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of LGALS3 mRNA CTD PMID:27153756 aflatoxin B1 decreases expression ISO Lgals3 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of LGALS3 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO LGALS3 (Homo sapiens) 6480464 Tretinoin results in decreased expression of LGALS3 mRNA CTD PMID:12875902 all-trans-retinoic acid increases expression ISO LGALS3 (Homo sapiens) 6480464 Tretinoin results in increased expression of LGALS3 mRNA CTD PMID:23724009 all-trans-retinoic acid decreases expression ISO Lgals3 (Mus musculus) 6480464 Tretinoin results in decreased expression of LGALS3 mRNA CTD PMID:16604517 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LGALS3 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of LGALS3 mRNA CTD PMID:30779732 aristolochic acid A increases expression ISO LGALS3 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of LGALS3 protein CTD PMID:33212167 arsenite(3-) multiple interactions ISO LGALS3 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to LGALS3 protein] and arsenite promotes the reaction [G3BP1 protein binds to LGALS3 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO LGALS3 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of LGALS3 mRNA CTD PMID:20458559 benzo[a]pyrene increases expression ISO Lgals3 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of LGALS3 mRNA CTD PMID:22228805 and PMID:23735875 benzo[a]pyrene increases methylation ISO LGALS3 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of LGALS3 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO LGALS3 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of LGALS3 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO LGALS3 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of LGALS3 mRNA and Benzo(a)pyrene results in increased expression of LGALS3 protein CTD PMID:16269432 more ... benzo[b]fluoranthene increases expression ISO LGALS3 (Homo sapiens) 6480464 benzo(b)fluoranthene results in increased expression of LGALS3 mRNA CTD PMID:16269432 beta-naphthoflavone increases expression ISO LGALS3 (Homo sapiens) 6480464 beta-Naphthoflavone results in increased expression of LGALS3 mRNA CTD PMID:19737606 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of LGALS3 mRNA CTD PMID:16648578 bezafibrate increases expression ISO Lgals3 (Mus musculus) 6480464 Bezafibrate results in increased expression of LGALS3 mRNA CTD PMID:17118139 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of LGALS3 protein CTD PMID:33002157 bis(2-ethylhexyl) phthalate increases expression ISO LGALS3 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of LGALS3 mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LGALS3 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO LGALS3 (Homo sapiens) 6480464 bisphenol A results in decreased expression of LGALS3 protein CTD PMID:34186270 bisphenol A increases expression ISO LGALS3 (Homo sapiens) 6480464 bisphenol A results in increased expression of LGALS3 protein CTD PMID:33376534 and PMID:37567409 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of LGALS3 mRNA CTD PMID:32145629 bisphenol A affects expression ISO LGALS3 (Homo sapiens) 6480464 bisphenol A affects the expression of LGALS3 mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of LGALS3 gene CTD PMID:28505145 bisphenol F increases expression ISO Lgals3 (Mus musculus) 6480464 bisphenol F results in increased expression of LGALS3 mRNA CTD PMID:30951980 bleomycin A2 increases expression ISO Lgals3 (Mus musculus) 6480464 Bleomycin results in increased expression of LGALS3 protein CTD PMID:26526764 bleomycin A2 multiple interactions ISO Lgals3 (Mus musculus) 6480464 NOS2 protein affects the reaction [Bleomycin results in increased expression of LGALS3 protein] CTD PMID:26526764 bucladesine multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA CTD PMID:20823114 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of LGALS3 mRNA CTD PMID:24136188 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of LGALS3 mRNA CTD PMID:22110744 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of LGALS3 mRNA CTD PMID:25993096 calcitriol decreases expression ISO LGALS3 (Homo sapiens) 6480464 Calcitriol results in decreased expression of LGALS3 mRNA CTD PMID:12875902 calyculin a increases expression ISO Lgals3 (Mus musculus) 6480464 calyculin A results in increased expression of LGALS3 mRNA CTD PMID:25270620 carbon nanotube affects expression ISO Lgals3 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of LGALS3 mRNA CTD PMID:23845593 carbon nanotube increases expression ISO Lgals3 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:27106021 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of LGALS3 mRNA CTD PMID:18500788 CGP 52608 multiple interactions ISO LGALS3 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to LGALS3 gene] CTD PMID:28238834 chloroform increases expression EXP 6480464 Chloroform results in increased expression of LGALS3 mRNA CTD PMID:17522070 choline multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA CTD PMID:20938992 ciglitazone multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [ciglitazone binds to PPARG protein] which results in increased expression of LGALS3 mRNA CTD PMID:16197558 cisplatin multiple interactions ISO LGALS3 (Homo sapiens) 6480464 4-benzyl-2-methyl-1 more ... CTD PMID:21368866 and PMID:21821001 cisplatin decreases response to substance ISO LGALS3 (Homo sapiens) 6480464 GAL3 protein results in decreased susceptibility to Cisplatin more ... CTD PMID:21368866 more ... cisplatin increases expression ISO LGALS3 (Homo sapiens) 6480464 Cisplatin results in increased expression of LGALS3 mRNA and Cisplatin results in increased expression of LGALS3 protein CTD PMID:21821001 and PMID:27392435 clofibrate increases expression ISO Lgals3 (Mus musculus) 6480464 Clofibrate results in increased expression of LGALS3 mRNA CTD PMID:17585979 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of LGALS3 mRNA CTD PMID:24386269 copper(II) sulfate increases expression ISO LGALS3 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of LGALS3 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of LGALS3 mRNA CTD PMID:26577399 and PMID:27523638 cycloheximide multiple interactions ISO LGALS3 (Homo sapiens) 6480464 Cycloheximide inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] CTD PMID:21821001 cyclosporin A increases expression ISO LGALS3 (Homo sapiens) 6480464 Cyclosporine results in increased expression of LGALS3 mRNA CTD PMID:25562108 and PMID:27989131 decabromodiphenyl ether decreases expression ISO LGALS3 (Homo sapiens) 6480464 decabromobiphenyl ether results in decreased expression of LGALS3 protein CTD PMID:31675489 dexamethasone multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [GCS-100 co-treated with Dexamethasone] results in decreased expression of LGALS3 protein CTD PMID:16166312 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of LGALS3 mRNA CTD PMID:17522070 diarsenic trioxide increases expression ISO LGALS3 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of LGALS3 mRNA CTD PMID:20458559 dibenz[a,h]anthracene increases expression ISO LGALS3 (Homo sapiens) 6480464 1 more ... CTD PMID:16269432 dibenzo[a,l]pyrene increases expression ISO LGALS3 (Homo sapiens) 6480464 dibenzo(a and l)pyrene results in increased expression of LGALS3 protein CTD PMID:18495319 diclofenac increases expression ISO Lgals3 (Mus musculus) 6480464 Diclofenac results in increased expression of LGALS3 mRNA CTD PMID:26934552 dicrotophos decreases expression ISO LGALS3 (Homo sapiens) 6480464 dicrotophos results in decreased expression of LGALS3 mRNA CTD PMID:28302478 diethylstilbestrol increases expression ISO Lgals3 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of LGALS3 mRNA CTD PMID:15289156 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of LGALS3 mRNA CTD PMID:15890375 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of LGALS3 mRNA CTD PMID:16122865 dioxygen increases expression ISO Lgals3 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of LGALS3 mRNA CTD PMID:17193925 dioxygen multiple interactions ISO Lgals3 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGALS3 mRNA and [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of LGALS3 mRNA CTD PMID:19640911 and PMID:30529165 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of LGALS3 protein and Oxygen results in increased expression of LGALS3 mRNA CTD PMID:22911455 and PMID:32003113 diquat increases expression ISO Lgals3 (Mus musculus) 6480464 Diquat results in increased expression of LGALS3 mRNA CTD PMID:36851058 diuron increases expression EXP 6480464 Diuron results in increased expression of LGALS3 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases response to substance ISO LGALS3 (Homo sapiens) 6480464 LGALS3 mRNA results in decreased susceptibility to Doxorubicin CTD PMID:16322897 doxorubicin increases expression ISO Lgals3 (Mus musculus) 6480464 Doxorubicin results in increased expression of LGALS3 mRNA CTD PMID:36227756 doxorubicin increases expression ISO LGALS3 (Homo sapiens) 6480464 Doxorubicin results in increased expression of LGALS3 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of LGALS3 mRNA CTD PMID:29391264 entinostat increases expression ISO LGALS3 (Homo sapiens) 6480464 entinostat results in increased expression of LGALS3 mRNA CTD PMID:26272509 entinostat multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of LGALS3 mRNA CTD PMID:17522070 etoposide affects response to substance ISO LGALS3 (Homo sapiens) 6480464 LGALS3 protein affects the susceptibility to Etoposide CTD PMID:16217747 fenamidone increases expression ISO Lgals3 (Mus musculus) 6480464 fenamidone results in increased expression of LGALS3 mRNA CTD PMID:27029645 flurbiprofen increases expression ISO Lgals3 (Mus musculus) 6480464 Flurbiprofen results in increased expression of LGALS3 mRNA CTD PMID:16949054 folic acid increases expression EXP 6480464 Folic Acid results in increased expression of LGALS3 mRNA CTD PMID:10980121 folic acid multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA CTD PMID:20938992 genistein increases expression ISO Lgals3 (Mus musculus) 6480464 Genistein results in increased expression of LGALS3 mRNA CTD PMID:15289156 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of LGALS3 mRNA CTD PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of LGALS3 mRNA CTD PMID:24136188 isoprenaline increases expression ISO Lgals3 (Mus musculus) 6480464 Isoproterenol results in increased expression of LGALS3 mRNA CTD PMID:20003209 ivermectin decreases expression ISO LGALS3 (Homo sapiens) 6480464 Ivermectin results in decreased expression of LGALS3 protein CTD PMID:32959892 L-ascorbic acid increases expression EXP 6480464 Ascorbic Acid results in increased expression of LGALS3 mRNA CTD PMID:15372504 L-methionine multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA CTD PMID:20938992 lactose affects binding ISO LGALS3 (Homo sapiens) 6480464 Lactose binds to LGALS3 protein CTD PMID:17385862 leflunomide increases expression ISO LGALS3 (Homo sapiens) 6480464 leflunomide results in increased expression of LGALS3 mRNA CTD PMID:28988120 and PMID:29427785 LY294002 multiple interactions ISO LGALS3 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of and affects the localization of LGALS3 protein more ... CTD PMID:21821001 LY294002 decreases response to substance ISO LGALS3 (Homo sapiens) 6480464 LGALS3 results in decreased susceptibility to 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one CTD PMID:21821001 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of LGALS3 mRNA CTD PMID:28801915 medroxyprogesterone acetate multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA CTD PMID:20823114 mercury dibromide increases expression ISO LGALS3 (Homo sapiens) 6480464 mercuric bromide results in increased expression of LGALS3 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of LGALS3 mRNA CTD PMID:15890375 methimazole increases expression ISO LGALS3 (Homo sapiens) 6480464 Methimazole results in increased expression of LGALS3 mRNA CTD PMID:20144635 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of LGALS3 gene CTD PMID:23303685 methylmercury chloride decreases expression ISO LGALS3 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of LGALS3 mRNA CTD PMID:23179753 and PMID:34089799 methylmercury chloride increases expression ISO LGALS3 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of LGALS3 mRNA CTD PMID:28001369 microcystin-LR increases expression ISO Lgals3 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of LGALS3 mRNA CTD PMID:17654400 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of LGALS3 mRNA CTD PMID:25972201 mitomycin C affects response to substance ISO LGALS3 (Homo sapiens) 6480464 LGALS3 protein affects the susceptibility to Mitomycin CTD PMID:16217747 monocrotaline multiple interactions EXP 6480464 [Monocrotaline co-treated with LGALS3 protein] inhibits the reaction [[Monocrotaline co-treated with TGFB1] results in decreased expression of MMP9 protein] more ... CTD PMID:27870162 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of LGALS3 gene CTD PMID:33148267 N-acetylsphingosine increases expression ISO LGALS3 (Homo sapiens) 6480464 N-acetylsphingosine results in increased expression of LGALS3 protein CTD PMID:21821001 N-acetylsphingosine decreases response to substance ISO LGALS3 (Homo sapiens) 6480464 LGALS3 results in decreased susceptibility to N-acetylsphingosine CTD PMID:21821001 N-acetylsphingosine multiple interactions ISO LGALS3 (Homo sapiens) 6480464 4-benzyl-2-methyl-1 more ... CTD PMID:21821001 N-ethyl-N-nitrosourea increases expression EXP 6480464 Ethylnitrosourea results in increased expression of LGALS3 mRNA CTD PMID:15954086 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA CTD PMID:19840844 N-methyl-N-nitrosourea decreases expression ISO Lgals3 (Mus musculus) 6480464 Methylnitrosourea results in decreased expression of LGALS3 mRNA CTD PMID:25270620 N-methyl-N-nitrosourea increases expression EXP 150530464 N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum RGD N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of LGALS3 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3 mRNA CTD PMID:28943392 N-nitrosodiethylamine multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LGALS3 mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of LGALS3 mRNA CTD PMID:15890375 and PMID:25380136 N-nitrosodimethylamine increases expression ISO LGALS3 (Homo sapiens) 6480464 Dimethylnitrosamine results in increased expression of LGALS3 mRNA CTD PMID:17547211 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of LGALS3 mRNA CTD PMID:19716841 naloxone increases expression EXP 6480464 Naloxone results in increased expression of LGALS3 mRNA CTD PMID:17522070 nickel atom increases expression ISO Lgals3 (Mus musculus) 6480464 Nickel results in increased expression of LGALS3 mRNA CTD PMID:12540486 nickel subsulfide increases expression EXP 6480464 nickel subsulfide results in increased expression of LGALS3 mRNA CTD PMID:21086188 nickel sulfate affects expression ISO Lgals3 (Mus musculus) 6480464 nickel sulfate affects the expression of LGALS3 mRNA CTD PMID:12718980 nickel sulfate decreases expression ISO LGALS3 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of LGALS3 mRNA CTD PMID:18651567 niclosamide increases expression ISO LGALS3 (Homo sapiens) 6480464 Niclosamide results in increased expression of LGALS3 mRNA CTD PMID:36318118 Nonylphenol increases expression ISO LGALS3 (Homo sapiens) 6480464 nonylphenol results in increased expression of LGALS3 protein CTD PMID:16054331 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of LGALS3 mRNA CTD PMID:23439660 ozone increases expression EXP 6480464 Ozone results in increased expression of LGALS3 protein CTD PMID:22727909 ozone multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LGALS3 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LGALS3 mRNA CTD PMID:34911549 panobinostat increases expression ISO LGALS3 (Homo sapiens) 6480464 panobinostat results in increased expression of LGALS3 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 paracetamol affects expression ISO Lgals3 (Mus musculus) 6480464 Acetaminophen affects the expression of LGALS3 mRNA CTD PMID:17562736 paracetamol decreases expression ISO LGALS3 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of LGALS3 mRNA CTD PMID:26690555 paracetamol affects response to substance ISO Lgals3 (Mus musculus) 6480464 LGALS3 protein affects the susceptibility to Acetaminophen CTD PMID:22461450 paracetamol multiple interactions ISO Lgals3 (Mus musculus) 6480464 LGALS3 protein affects the reaction [Acetaminophen results in increased expression of CCL20 mRNA] more ... CTD PMID:22461450 paracetamol increases expression ISO Lgals3 (Mus musculus) 6480464 Acetaminophen results in increased expression of LGALS3 mRNA and Acetaminophen results in increased expression of LGALS3 protein CTD PMID:22461450 and PMID:34724096 paraquat increases expression EXP 6480464 Paraquat results in increased expression of LGALS3 mRNA and Paraquat results in increased expression of LGALS3 protein CTD PMID:24521700 and PMID:32680482 perfluorooctane-1-sulfonic acid multiple interactions ISO Lgals3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LGALS3 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO LGALS3 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of LGALS3 protein CTD PMID:26879310 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of LGALS3 gene CTD PMID:33148267 phenacetin increases expression EXP 6480464 Phenacetin results in increased expression of LGALS3 mRNA CTD PMID:17082564 and PMID:17698508 phenobarbital multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LGALS3 mRNA and NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LGALS3 mRNA] CTD PMID:19482888 and PMID:24535843 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of LGALS3 mRNA CTD PMID:19162173 phenobarbital increases expression ISO Lgals3 (Mus musculus) 6480464 Phenobarbital results in increased expression of LGALS3 mRNA CTD PMID:19482888 phenylhydrazine increases expression EXP 6480464 phenylhydrazine results in increased expression of LGALS3 mRNA CTD PMID:17082564 and PMID:17698508 phenylmercury acetate increases expression ISO LGALS3 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of LGALS3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA CTD PMID:19840844 phosgene affects expression ISO Lgals3 (Mus musculus) 6480464 Phosgene affects the expression of LGALS3 mRNA CTD PMID:16300373 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of LGALS3 mRNA CTD PMID:15890375 pirinixic acid multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LGALS3 mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of LGALS3 mRNA CTD PMID:15890375 pirinixic acid increases expression ISO Lgals3 (Mus musculus) 6480464 pirinixic acid results in increased expression of LGALS3 mRNA CTD PMID:17118139 potassium dichromate increases expression ISO LGALS3 (Homo sapiens) 6480464 Potassium Dichromate results in increased expression of LGALS3 protein CTD PMID:23718831 progesterone affects metabolic processing ISO Lgals3 (Mus musculus) 6480464 LGALS3 protein affects the metabolism of Progesterone CTD PMID:17242467 progesterone multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of LGALS3 mRNA CTD PMID:20660070 quercetin increases expression ISO LGALS3 (Homo sapiens) 6480464 Quercetin results in increased expression of LGALS3 mRNA CTD PMID:21632981 quercetin multiple interactions EXP 150530464 Quercetin inhibits the reaction [N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum] RGD quinolin-8-ol decreases expression ISO LGALS3 (Homo sapiens) 6480464 Oxyquinoline results in decreased expression of LGALS3 mRNA CTD PMID:21632981 quinoline increases expression ISO LGALS3 (Homo sapiens) 6480464 quinoline analog results in increased expression of LGALS3 protein CTD PMID:18645022 rac-lactic acid increases expression ISO LGALS3 (Homo sapiens) 6480464 Lactic Acid results in increased expression of LGALS3 mRNA CTD PMID:30851411 reactive oxygen species increases abundance ISO LGALS3 (Homo sapiens) 6480464 LGALS3 protein results in increased abundance of Reactive Oxygen Species CTD PMID:34894372 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of LGALS3 mRNA CTD PMID:25905778 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of LGALS3 mRNA CTD PMID:25905778 rotenone increases expression EXP 6480464 Rotenone results in increased expression of LGALS3 mRNA CTD PMID:27900601 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO LGALS3 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of LGALS3 mRNA CTD PMID:36336211 and PMID:37544576 SB 431542 multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO Lgals3 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of LGALS3 mRNA and Silicon Dioxide results in increased expression of LGALS3 protein CTD PMID:23221170 more ... silicon dioxide increases expression ISO LGALS3 (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of LGALS3 protein CTD PMID:36223831 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of LGALS3 mRNA CTD PMID:21602193 and PMID:22431001 sodium arsenite decreases expression ISO Lgals3 (Mus musculus) 6480464 sodium arsenite results in decreased expression of LGALS3 protein CTD PMID:29044176 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of LGALS3 mRNA CTD PMID:25993096 sodium fluoride decreases expression ISO Lgals3 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of LGALS3 protein CTD PMID:28918527 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of LGALS3 mRNA and vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LGALS3 mRNA] CTD PMID:16684804 and PMID:25905778 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of LGALS3 mRNA CTD PMID:16684804 sulindac multiple interactions ISO LGALS3 (Homo sapiens) 6480464 Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3 mRNA] CTD PMID:15190207 sunitinib decreases expression ISO LGALS3 (Homo sapiens) 6480464 Sunitinib results in decreased expression of LGALS3 mRNA CTD PMID:31533062 tamoxifen affects expression ISO LGALS3 (Homo sapiens) 6480464 Tamoxifen affects the expression of LGALS3 mRNA CTD PMID:14699072 temozolomide decreases expression ISO LGALS3 (Homo sapiens) 6480464 Temozolomide results in decreased expression of LGALS3 mRNA CTD PMID:31758290 testosterone increases expression ISO Lgals3 (Mus musculus) 6480464 Testosterone deficiency results in increased expression of LGALS3 mRNA CTD PMID:33848595 testosterone decreases expression ISO LGALS3 (Homo sapiens) 6480464 Testosterone results in decreased expression of LGALS3 mRNA CTD PMID:33359661 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of LGALS3 mRNA and Carbon Tetrachloride results in increased expression of LGALS3 protein CTD PMID:12629582 more ... tetrachloromethane decreases expression ISO Lgals3 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of LGALS3 protein CTD PMID:29044176 tetrachloromethane multiple interactions EXP 6480464 Carbon Tetrachloride promotes the reaction [PURB protein binds to LGALS3 promoter] and schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LGALS3 mRNA] CTD PMID:16309856 and PMID:31150632 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of LGALS3 mRNA CTD PMID:12734012 tetrachloromethane multiple interactions ISO Lgals3 (Mus musculus) 6480464 LGALS3 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] more ... CTD PMID:16549783 and PMID:23798564 tetrachloromethane affects expression ISO Lgals3 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of LGALS3 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO Lgals3 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of LGALS3 mRNA and Carbon Tetrachloride results in increased expression of LGALS3 protein CTD PMID:16549783 more ... tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of LGALS3 mRNA CTD PMID:17522070 theophylline increases expression EXP 6480464 Theophylline results in increased expression of LGALS3 mRNA CTD PMID:17522070 thioacetamide multiple interactions ISO Lgals3 (Mus musculus) 6480464 MGAT5 protein affects the reaction [Thioacetamide results in increased expression of LGALS3 mRNA] CTD PMID:23798564 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of LGALS3 mRNA CTD PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3 mRNA CTD PMID:28943392 thioacetamide increases expression ISO Lgals3 (Mus musculus) 6480464 Thioacetamide results in increased expression of LGALS3 mRNA CTD PMID:23798564 titanium dioxide increases expression ISO Lgals3 (Mus musculus) 6480464 titanium dioxide results in increased expression of LGALS3 mRNA CTD PMID:23409001 more ... tremolite asbestos increases expression ISO Lgals3 (Mus musculus) 6480464 tremolite results in increased expression of LGALS3 mRNA CTD PMID:29279043 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of LGALS3 gene CTD PMID:27618143 trichostatin A increases expression ISO LGALS3 (Homo sapiens) 6480464 trichostatin A results in increased expression of LGALS3 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 triclosan increases expression ISO LGALS3 (Homo sapiens) 6480464 Triclosan results in increased expression of LGALS3 mRNA CTD PMID:30510588 tris(2-butoxyethyl) phosphate affects expression ISO LGALS3 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of LGALS3 mRNA CTD PMID:29024780 tungsten decreases expression ISO Lgals3 (Mus musculus) 6480464 Tungsten results in decreased expression of LGALS3 mRNA CTD PMID:30912803 tunicamycin increases expression ISO Lgals3 (Mus musculus) 6480464 Tunicamycin results in increased expression of LGALS3 mRNA CTD PMID:17127020 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of LGALS3 mRNA CTD PMID:24136188 valproic acid affects expression ISO Lgals3 (Mus musculus) 6480464 Valproic Acid affects the expression of LGALS3 mRNA CTD PMID:17963808 valproic acid multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 valproic acid increases expression ISO LGALS3 (Homo sapiens) 6480464 Valproic Acid results in increased expression of LGALS3 mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO LGALS3 (Homo sapiens) 6480464 Valproic Acid affects the expression of LGALS3 mRNA CTD PMID:25979313 vanadyl sulfate multiple interactions EXP 6480464 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LGALS3 mRNA] CTD PMID:16684804 vancomycin decreases expression ISO Lgals3 (Mus musculus) 6480464 Vancomycin results in decreased expression of LGALS3 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of LGALS3 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of LGALS3 mRNA CTD PMID:23034163 vorinostat increases expression ISO LGALS3 (Homo sapiens) 6480464 vorinostat results in increased expression of LGALS3 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO LGALS3 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 zinc oxide decreases expression EXP 6480464 Zinc Oxide results in decreased expression of LGALS3 protein CTD PMID:33205376